Michael F. Mahoney
Net Worth

Last updated:

What is Michael F. Mahoney net worth?

The estimated net worth of Mr. Michael F. Mahoney is at least $281,264,994 as of 5 Nov 2024. He owns shares worth $158,114,048 as insider, has earned $112,000,946 from insider trading and has received compensation worth at least $11,150,000 in Boston Scientific Corporation.

What is the salary of Michael F. Mahoney?

Mr. Michael F. Mahoney salary is $2,230,000 per year as Chairman, Pres & Chief Executive Officer in Boston Scientific Corporation.

How old is Michael F. Mahoney?

Mr. Michael F. Mahoney is 60 years old, born in 1965.

What stocks does Michael F. Mahoney currently own?

As insider, Mr. Michael F. Mahoney owns shares in one company:

Company Title Shares Price per share Total value
Boston Scientific Corporation (BSX) Chairman, Pres & Chief Executive Officer 1,521,205 $103.94 $158,114,048

What does Boston Scientific Corporation do?

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX logo
BSX
Boston Scientific Corporation
$103.94

Michael F. Mahoney insider trading

Boston Scientific Corporation

Mr. Michael F. Mahoney has made 14 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 259,207 units of BSX stock on 3 Nov 2020. As of 5 Nov 2024 he still owns at least 1,521,205 units of BSX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 56,211 $17.26 $970,202
Option
Common Stock 55,676 $16.31 $908,076
Sale
Common Stock 160,182 $84.74 $13,573,823
Sale
Common Stock 2,596 $85.17 $221,109
Option
Stock Option (Right to Buy) 56,211 $17.26 $970,202
Option
Stock Option (Right to Buy) 55,676 $16.31 $908,076
Sale
Common Stock 82,085 $84.94 $6,972,464
Option
Stock Option (Right to Buy) 56,211 $17.26 $970,202
Option
Stock Option (Right to Buy) 55,675 $16.31 $908,059
Option
Common Stock 56,211 $17.26 $970,202
Option
Common Stock 55,675 $16.31 $908,059
Sale
Common Stock 80,692 $84.31 $6,803,385
Option
Common Stock 56,211 $17.26 $970,202
Option
Stock Option (Right to Buy) 56,211 $17.26 $970,202
Sale
Common Stock 162,777 $81.17 $13,212,609
Option
Stock Option (Right to Buy) 55,675 $16.31 $908,059
Option
Common Stock 55,675 $16.31 $908,059
Option
Common Stock 16,307 N/A N/A
Option
Deferred Stock Units 16,307 N/A N/A
Option
Common Stock 18,333 N/A N/A
Option
Restricted Stock Units 18,333 N/A N/A
Option
Restricted Stock Units 16,265 N/A N/A
Option
Common Stock 16,265 N/A N/A
Option
Common Stock 95,919 N/A N/A
Option
Performance Share Units 95,919 N/A N/A
Option
Common Stock 57,681 $13.08 $754,467
Option
Stock Option (Right to Buy) 55,675 $16.31 $908,059
Option
Stock Option (Right to Buy) 57,681 $13.08 $754,467
Sale
Common Stock 113,356 $52.51 $5,951,983
Option
Common Stock 55,675 $16.31 $908,059
Option
Stock Option (Right to Buy) 57,680 $13.08 $754,454
Option
Stock Option (Right to Buy) 55,675 $16.31 $908,059
Option
Common Stock 57,680 $13.08 $754,454
Sale
Common Stock 113,355 $52.09 $5,904,435
Option
Common Stock 55,675 $16.31 $908,059
Sale
Common Stock 113,355 $53.91 $6,110,401
Option
Stock Option (Right to Buy) 57,680 $13.08 $754,454
Option
Common Stock 55,675 $16.31 $908,059
Option
Common Stock 57,680 $13.08 $754,454
Option
Stock Option (Right to Buy) 55,675 $16.31 $908,059
Option
Deferred Stock Units 16,825 N/A N/A
Option
Common Stock 16,825 N/A N/A
Option
Common Stock 16,307 N/A N/A
Option
Deferred Stock Units 16,307 N/A N/A
Option
Restricted Stock Units 18,333 N/A N/A
Option
Common Stock 18,333 N/A N/A
Option
Restricted Stock Units 16,264 N/A N/A
Option
Common Stock 16,264 N/A N/A
Option
Deferred Stock Units 18,330 N/A N/A
Option
Common Stock 18,330 N/A N/A
Option
Deferred Stock Units 16,825 N/A N/A
Option
Common Stock 16,825 N/A N/A
Option
Restricted Stock Units 18,333 N/A N/A
Option
Deferred Stock Units 16,307 N/A N/A
Option
Common Stock 16,307 N/A N/A
Option
Common Stock 18,333 N/A N/A
Option
Deferred Stock Units 18,457 N/A N/A
Option
Common Stock 18,457 N/A N/A
Option
Common Stock 60,635 N/A N/A
Option
Performance Share Units 60,635 N/A N/A
Option
Common Stock 201,042 $6.84 $1,374,122
Option
Stock Option (Right to Buy) 201,042 $6.84 $1,374,122
Sale
Common Stock 201,042 $43.05 $8,655,662
Sale
Common Stock 201,042 $42.91 $8,626,511
Option
Common Stock 201,042 $6.84 $1,374,122
Option
Stock Option (Right to Buy) 201,042 $6.84 $1,374,122
Option
Common Stock 201,041 $6.84 $1,374,115
Option
Stock Option (Right to Buy) 201,041 $6.84 $1,374,115
Sale
Common Stock 201,041 $44.57 $8,959,995
Option
Stock Option (Right to Buy) 201,043 $6.84 $1,374,129
Option
Common Stock 201,043 $6.84 $1,374,129
Sale
Common Stock 201,043 $45.74 $9,194,702
Option
Common Stock 201,041 $6.84 $1,374,115
Option
Stock Option (Right to Buy) 201,041 $6.84 $1,374,115
Sale
Common Stock 201,041 $43.41 $8,726,587
Option
Common Stock 18,330 N/A N/A
Option
Deferred Stock Units 18,330 N/A N/A
Option
Common Stock 23,175 N/A N/A
Option
Deferred Stock Units 23,175 N/A N/A
Option
Common Stock 16,824 N/A N/A
Option
Deferred Stock Units 16,824 N/A N/A
Option
Deferred Stock Units 16,306 N/A N/A
Option
Common Stock 16,306 N/A N/A
Option
Deferred Stock Units 18,457 N/A N/A
Option
Common Stock 18,457 N/A N/A
Option
Common Stock 108,797 N/A N/A
Option
Performance Share Units 108,797 N/A N/A
Sale
Common Stock 259,207 $35.06 $9,087,279
Option
Deferred Stock Units 18,330 N/A N/A
Option
Common Stock 18,330 N/A N/A
Option
Deferred Stock Units 23,759 N/A N/A
Option
Common Stock 23,759 N/A N/A
Option
Common Stock 23,175 N/A N/A
Option
Deferred Stock Units 23,175 N/A N/A
Option
Common Stock 16,824 N/A N/A
Option
Deferred Stock Units 16,824 N/A N/A
Option
Deferred Stock Units 18,457 N/A N/A
Option
Common Stock 18,457 N/A N/A
Option
Performance Share Units 89,449 N/A N/A
Option
Common Stock 89,449 N/A N/A